MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	40.02M
Revenue (ttm)	7.54M
Net Income (ttm)	-6.37M
Shares Out	58.85M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,866
Average Volume	32,112
Open	0.6400
Previous Close	0.6300
Day's Range	0.6400 - 0.7500
52-Week Range	0.5000 - 2.0900
Beta	0.76
RSI	60.18
Earnings Date	Nov 26, 2025

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.